ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

October 15, 2004

Shubik Subcommittee Fails To Agree On Draft Document

February 13, 1976

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

August 26, 1988

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

In Brief: Kennedy To Hold Hearing on Mammography Reimbursement, Waxman On Reauthrization

January 15, 1988